These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 32118496)
1. Patient Experiences with Compounded Topical Pain Creams. McPherson T; Fontane P; Bilger R J Pain Palliat Care Pharmacother; 2020 Jun; 34(2):82-89. PubMed ID: 32118496 [TBL] [Abstract][Full Text] [Related]
2. A brief survey on prescriber beliefs regarding compounded topical pain medications. Warner M; Tuder D Int J Pharm Compd; 2014; 18(3):182-8. PubMed ID: 25306764 [TBL] [Abstract][Full Text] [Related]
3. Retrospective Evaluation on the Analgesic Activities of 2 Compounded Topical Creams and Voltaren Gel in Chronic Noncancer Pain. Somberg JC; Molnar J Am J Ther; 2015; 22(5):342-9. PubMed ID: 26352120 [TBL] [Abstract][Full Text] [Related]
4. Patient experiences with compounded medications. McPherson T; Fontane P; Bilger R J Am Pharm Assoc (2003); 2019; 59(5):670-677.e2. PubMed ID: 31227417 [TBL] [Abstract][Full Text] [Related]
5. Management of chronic neuropathic pain with single and compounded topical analgesics. Knezevic NN; Tverdohleb T; Nikibin F; Knezevic I; Candido KD Pain Manag; 2017 Nov; 7(6):537-558. PubMed ID: 29125423 [TBL] [Abstract][Full Text] [Related]
6. Transdermal and Topical Drug Administration in the Treatment of Pain. Leppert W; Malec-Milewska M; Zajaczkowska R; Wordliczek J Molecules; 2018 Mar; 23(3):. PubMed ID: 29562618 [TBL] [Abstract][Full Text] [Related]
7. Compounded pain formulations: what is the evidence? Asbill S; Sweitzer SM; Spigener S; Romero-Sandoval A Int J Pharm Compd; 2014; 18(4):278-86. PubMed ID: 25474856 [TBL] [Abstract][Full Text] [Related]
10. The role of transdermal compounding in opioid safety. Bucher CV; Day AJ; Carvalho M J Opioid Manag; 2018; 14(1):17-22. PubMed ID: 29508892 [TBL] [Abstract][Full Text] [Related]
11. Retrospective Study on the Analgesic Activity of a Topical (TT-CTAC) Cream in Patients With Diabetic Neuropathy and Other Chronic Pain Conditions. Somberg JC; Molnar J Am J Ther; 2015; 22(3):214-21. PubMed ID: 25859821 [TBL] [Abstract][Full Text] [Related]
12. Topical treatments of skin pain: a general review with a focus on hidradenitis suppurativa with topical agents. Scheinfeld N Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046456 [TBL] [Abstract][Full Text] [Related]
15. Compounded ointment results in severe toxicity in a pediatric patient. Sullivan RW; Ryzewski M; Holland MG; Marraffa JM Pediatr Emerg Care; 2013 Nov; 29(11):1220-2. PubMed ID: 24196095 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Percutaneous Absorption of Ketamine HCl, Gabapentin, Clonidine HCl, and Baclofen, in Compounded Transdermal Pain Formulations, Using the Franz Finite Dose Model. Bassani AS; Banov D Pain Med; 2016 Feb; 17(2):230-8. PubMed ID: 26352507 [TBL] [Abstract][Full Text] [Related]
17. Use of compounded topical analgesics--results of an Internet survey. Ness TJ; Jones L; Smith H Reg Anesth Pain Med; 2002; 27(3):309-12. PubMed ID: 12016606 [TBL] [Abstract][Full Text] [Related]
18. Skin matters! The role of keratinocytes in nociception: a rational argument for the development of topical analgesics. Keppel Hesselink JM; Kopsky DJ; Bhaskar AK J Pain Res; 2017; 10():1-8. PubMed ID: 28031725 [TBL] [Abstract][Full Text] [Related]
19. Systemic Adverse Events Associated with Compounded Topical Pain Products. Kim J; Konkel K; Jones SC; McCulley L Drug Saf; 2020 May; 43(5):497-501. PubMed ID: 32248428 [No Abstract] [Full Text] [Related]
20. Topical treatment of neuropathic pain using compounded medications. Zur E Clin J Pain; 2014 Jan; 30(1):73-91. PubMed ID: 23446080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]